Heterozygous pathogenic variants in RB1 in constitutional DNA represents not only a risk factor for the development of retinoblastoma but also other subsequent primary malignancies (SPM) particularly soft tissue sarcoma and osteosarcoma [29, 30]. This evidence concerns the gene RB1 and osteosarcoma.